Evidence map›Paper›PMID 39308938›Full record

ReviewBiotechnology reports (Amsterdam, Netherlands)2024

Eco-smart biocontrol strategies utilizing potent microbes for sustainable management of phytopathogenic diseases.

Ihtisham Ul Haq, Kashif Rahim, Galal Yahya, Bushra Ijaz, Sajida Maryam, Najeeba Parre Paker

Abstract readReview
In one paragraph

Review in Biotechnology reports (Amsterdam, Netherlands), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ihtisham Ul HaqPrograma de Pos-graduacao em Invacao Tecnologia, Universidade de Minas Gerais Belo Horizonte, Brazil.
Kashif RahimCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Galal YahyaDepartment of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Bushra IjazDepartment of Functional and Evolutionary Ecology, University of Vienna, Austria.
Sajida MaryamDepartment of Physical Chemistry and Technology of Polymers, Silesian University of Technology, M. Strzody 9, 44-100, Gliwice, Poland.
Najeeba Parre PakerDepartment of Biology, University of York, Wentworth Way, York, YO10 5DD, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plants have an impact on the economy because they are used in the food and medical industries. Plants are a source of macro- and micronutrients for the health of humans and animals; however, the rise in microbial diseases has put plant health and yield at risk. Because there are insufficient controls, microbial infections annually impact approximately 25 % of the world's plant crops. Alternative strategies, such as biocontrol, are required to fight these illnesses. This review discusses the potential uses of recently discovered microorganisms because they are safe, effective, and unlikely to cause drug resistance. They have no negative effects on soil microbiology or the environment because they are environmentally benign. Biological control enhances indigenous microbiomes by reducing bacterial wilt, brown blotch, fire blight, and crown gall. More research is required to make these biocontrol agents more stable, effective, and less toxic before they can be used in commercial settings.

Indexed as

BacteriophagesBiocontrolMode of actionsPhytopathogensPlant diseases

Identifiers

PMID39308938
PMCPMC11415593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.